MaxCyte, Inc.
MXCT
$2.61
$0.062.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.60M | -11.56M | -9.38M | -9.53M | -5.28M |
| Total Depreciation and Amortization | 1.06M | 1.07M | 1.08M | 1.11M | 1.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.43M | 2.92M | 2.25M | 1.29M | 2.38M |
| Change in Net Operating Assets | -1.71M | 3.19M | 1.21M | -3.44M | 2.78M |
| Cash from Operations | -7.82M | -4.39M | -4.83M | -10.56M | 981.00K |
| Capital Expenditure | -147.00K | -406.00K | -294.00K | -804.00K | -915.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.52M | 4.01M | 19.68M | -13.59M | -3.22M |
| Cash from Investing | -1.67M | 3.61M | 19.39M | -14.40M | -4.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 412.00K | 228.00K | 713.00K | 703.00K | 493.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 412.00K | 228.00K | 713.00K | 703.00K | 493.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.07M | -555.00K | 15.26M | -24.26M | -2.67M |